Drug wholesale prices up over 7% in 2007

Share this article:

Pharmaceutical manufacturers increased wholesale prices for the 50 top-selling branded medications by an average of 7.82% in 2007, after increases of 6.73% and 6.22% in the previous two years, according to data from marketing research firm Delta Marketing Dynamics.

The most recent increase is almost double the overall U.S. economy's 4.1% annual inflation rate last year, a report in today's Wall Street Journal said.

GlaxoSmithKline raised the price of its antidepressant Wellbutrin XL by 44.5% from 2005 to 2007. Sanofi Aventis raised the price of its sleep drug Ambien 70.1%.

Shire upped the price of its attention-deficit disorder treatement, Adderall XR, by 33.5%.

Pfizer's cholesterol-fighting Lipitor -- the world's top-selling Rx drug with $13 billion in sales, rose 16%.

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.